Greenleaf Trust’s Manhattan Associates MANH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,542
Closed -$205K 897
2026
Q1
$205K Buy
+1,542
New +$231K ﹤0.01% 775
2025
Q4
Sell
-1,052
Closed -$216K 844
2025
Q3
$216K Sell
1,052
-454
-30% -$96K ﹤0.01% 760
2025
Q2
$297K Sell
1,506
-551
-27% -$100K ﹤0.01% 632
2025
Q1
$356K Buy
2,057
+90
+5% +$18.7K ﹤0.01% 590
2024
Q4
$532K Buy
1,967
+1,166
+146% +$332K ﹤0.01% 492
2024
Q3
$225K Buy
+801
New +$204K ﹤0.01% 760
2019
Q4
Sell
-3,544
Closed -$286K 568
2019
Q3
$286K Buy
+3,544
New +$284K ﹤0.01% 423

Other funds holding MANH

Greenleaf Trust's MANH Position: Q2 2026 in Review

Greenleaf Trust sold out of Manhattan Associates (MANH) in Q2 2026, closing a stake of 1,542 shares — an estimated $205K sold.

Greenleaf Trust first reported a position in MANH in Q3 2019 and held it in 7 quarters. The position peaked at $532K in Q4 2024. 505 funds tracked by Wall St. Rank hold MANH as of Q2 2026.

  • Greenleaf Trust reported no remaining Manhattan Associates position as of Q2 2026 after selling out during the quarter.
  • Greenleaf Trust sold 1,542 Manhattan Associates shares in Q2 2026, an estimated $205K.
  • Greenleaf Trust first reported a position in Manhattan Associates in Q3 2019 and held it in 7 quarters.
  • Greenleaf Trust's Manhattan Associates position peaked at $532K in Q4 2024.
  • 505 funds tracked by Wall St. Rank held Manhattan Associates as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.